HKBU’s Aptamer for X-Linked Hypophosphatemia Receives Orphan Drug Status

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Oncolytics Biotech Highlights 2024 Milestones, Prepares for 2025

NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS

Sumitomo Pharma America Announces FDA Approval of GEMTESA for Overactive Bladder

Keymed Biosciences Announces Approval of Stapokibart for Chronic Rhinosinusitis

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options 

Ractigen Therapeutics Doses First Patient in Phase I Trial for RAG-17 in SOD1-ALS

Qilu Pharmaceutical Reports Preliminary Results of Phase Ia Study on QLS32015

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure 

Korea University Researchers Explore Ascorbic Acid and FGF4 in Regenerative Medicine

Children’s Colorado Signs Agreement with TriWest to Preserve Access to Pediatric Care for Military Families